Search results

For the journal "The Journal of infectious diseases"
 10 articles found

Search results

For the journal "The Journal of infectious diseases"
 10 articles found

 Japanese Encephalitis
Genotype III-Based Japanese Encephalitis Vaccines Exhibit Diminished Neutralizing Response to Re-emerging Genotype V

Published on 02/06/2026 |  Original article (Full-text)  | Ah-Ra Lee et al. | The Journal of infectious diseases 2024; aop: 10.1093/infdis/jiae589 1 min.

Japanese encephalitis (JE) has been predominantly controlled through vaccination. However, the isolation of JE virus (JEV) genotype V (GV) in China in 2009, and the subsequent alarming increase in JE cases in the Republic of Korea since 2010, present a new challenge. Serum samples from individuals vaccinated...

 Japanese Encephalitis
Viral Infection and the Blood-Brain Barrier: Molecular Research Insights and Therapies

Published on 03/03/2026 |  Original article (Abstract)  | Sarah A Boardman et al. | The Journal of infectious diseases. Volume 232(6). 1 min.

The blood-brain barrier (BBB) protects the brain from pathogenic microorganisms. Neurologic complications from viral infections, including herpes simplex virus, varicella zoster virus, HIV, Japanese encephalitis virus, and SARS-CoV-2, are linked to BBB dysfunction and loss of barrier integrity. Increased...

 Diphtheria
Half-life estimation of pertussis-specific maternal antibodies in (pre)term infants after in-pregnancy tetanus, diphtheria, acellular pertussis vaccination

Published on 20/01/2026 |  Original article (Abstract)  | Stefan Embacher et al. | The Journal of infectious diseases 2023; 228(11): 1640-8 1 min.

To reduce the risk of pertussis related morbidity and mortality in early life, an increasing number of countries recommend maternal pertussis vaccination. Hence, there is limited knowledge about half-lives of vaccine-induced pertussis-specific maternal antibodies, especially in preterm infants and factors...

 Hepatitis A
The Burden of Hepatitis A Outbreaks in the United States: Health Outcomes, Economic Costs, and Management Strategies

Published on 17/06/2025 |  Original article (Abstract)  | Emily K Horn et al. | The Journal of infectious diseases 2024; 230(1): 5 1 min.

Hepatitis A (HepA) vaccines are recommended for United States (US) adults at risk of HepA. Ongoing US HepA outbreaks since 2016 have primarily spread person-to-person, especially among at-risk groups. We investigated the health outcomes, economic burden, and outbreak management considerations associated...

 Chikungunya
Results of a nationally representative seroprevalence survey of chikungunya virus in Bangladesh

Published on 03/06/2025 |  Original article (Abstract)  | Sam W Allen et al. | The Journal of infectious diseases 2024; 230(5):  1 min.

There is an increasing global burden from chikungunya virus (CHIKV). Bangladesh reported a major epidemic in 2017, however, it was unclear if there had been prior widespread transmission. We conducted a nationally representative seroprevalence survey in 70 randomly selected communities immediately prior...